Anti‐tuberculosis agents may be associated with myelodysplastic syndromes

Lignende værker

• Rigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signaling transduction pathways in high-grade myelodysplastic syndrome
  af: Xu, Feng, et al.
  Udgivet: (2014)
• Meta-analysis on hypomethylating agents in myelodysplastic syndromes
  af: Herbst, Christine, et al.
  Udgivet: (2010)
• Transplantation for Myelodysplastic Syndrome in the Era of Hypomethylating Agents
  af: Gerds, Aaron T., et al.
  Udgivet: (2012)
• Localized lymphadenopathy with myelodysplastic syndrome associated with tuberculosis
  af: Nakaya, Aya, et al.
  Udgivet: (2019)
• Response to Hypomethylating Agents in Myelodysplastic Syndrome Is Associated With Emergence of Novel TCR Clonotypes
  af: Abbas, Hussein A., et al.
  Udgivet: (2021)